Search

Your search keyword '"Kelley, Colleen F"' showing total 378 results

Search Constraints

Start Over You searched for: Author "Kelley, Colleen F" Remove constraint Author: "Kelley, Colleen F"
378 results on '"Kelley, Colleen F"'

Search Results

1. HPTN 083‐02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study

2. Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials

3. Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 20211

4. The Comparability of Men Who Have Sex With Men Recruited From Venue-Time-Space Sampling and Facebook: A Cohort Study

5. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.

7. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

9. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

10. Risk of COVID-19 after natural infection or vaccination

11. “Cure” Versus “Clinical Remission”: The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication

12. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

13. Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

14. Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention Trials.

16. Corrigendum to – “Single oral dose for HIV pre or post-exposure prophylaxis: user desirability and biological efficacy in macaques” [eBioMedicine 58(2020) 102894]

17. Early Tecovirimat Treatment for Mpox Disease Among People With HIV

20. Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV.

21. Associations Between HIV and Severe Mpox in an Atlanta Cohort.

22. 2896. Oral PrEP Uptake among HVTN 704/HPTN 085 Participants: Implications for the Future of Biomedical HIV Prevention Trials

23. Associations between HIV and Severe Mpox in an Atlanta Cohort

24. Risk of COVID-19 after natural infection or vaccination

27. Lack of health insurance is associated with delays in PrEP initiation among young black men who have sex with men in Atlanta, US: a longitudinal cohort study

34. Repeated rectal application of a hyperosmolar lubricant is associated with microbiota shifts but does not affect PrEP drug concentrations: results from a randomized trial in men who have sex with men

35. HIV, asymptomatic STI, and the rectal mucosal immune environment among young men who have sex with men

39. Severe Acute Respiratory Syndrome Coronavirus 2 Evolution and Escape From Combination Monoclonal Antibody Treatment in a Person With HIV

43. Pharmacology of boosted and unboosted integrase strand transfer inhibitors for two-dose event-driven HIV prevention regimens among men

45. "Do We Stay or Do We Go?" The Impact of Anti-LGBTQ+ Legislation on the HIV Workforce in the South.

46. The association between comorbidities and coronavirus disease 2019 hospitalization among people with HIV differs by age

48. C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 ‘LIVE-AIR’ trial

49. Coronavirus Disease 2019 (COVID-19) Vaccines and Pregnancy

Catalog

Books, media, physical & digital resources